Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Treasury Shares (2016 - 2025)

Altimmune (ALT) has disclosed Treasury Shares for 16 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares rose 44.85% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 44.85% increase, with the full-year FY2024 number at $858290.0, up 42.06% from a year prior.
  • Treasury Shares was $1.1 million for Q3 2025 at Altimmune, up from $1.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.1 million in Q3 2025 to a low of $33636.0 in Q2 2022.
  • A 5-year average of $562896.3 and a median of $618543.0 in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: plummeted 84.08% in 2022, then skyrocketed 1744.5% in 2023.
  • Altimmune's Treasury Shares stood at $74000.0 in 2021, then surged by 460.11% to $414485.0 in 2022, then skyrocketed by 45.76% to $604167.0 in 2023, then soared by 42.06% to $858290.0 in 2024, then soared by 32.35% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for ALT's Treasury Shares are $1.1 million (Q3 2025), $1.0 million (Q2 2025), and $1.1 million (Q1 2025).